HAS Corporate Logo HAS Corporate Logo
  • Home
  • About
    • Partnerships
  • Services
    • Market Access Analytics and Insight
    • NICE HTA Strategy and Submission
    • Health Economics and Outcomes Research (HEOR)
    • Strategy Development
    • Reimbursement Strategy and Support
    • NHS Drug Tariff Submission Support
    • Private healthcare
    • Value Proposition Development for MedTech
    • Primary Care Market Insights
    • Stakeholder Engagement for Health Technologies
    • Sustainability and NET Zero for MedTech
    • Evidence Generation and Management
    • Dashboard Tools for Market Access
    • MedTech Sales Team Empowerment
    • NHS MedTech Business Case Formulation
  • Blog
  • Resources
Contact Us
  • Sun images
  • Vector Images
HAS Corporate Logo
  • Home
  • About
    • Partnerships
  • Services
    • Market Access Analytics and Insight
    • NICE HTA Strategy and Submission
    • Health Economics and Outcomes Research (HEOR)
    • Strategy Development
    • Reimbursement Strategy and Support
    • NHS Drug Tariff Submission Support
    • Private healthcare
    • Value Proposition Development for MedTech
    • Primary Care Market Insights
    • Stakeholder Engagement for Health Technologies
    • Sustainability and NET Zero for MedTech
    • Evidence Generation and Management
    • Dashboard Tools for Market Access
    • MedTech Sales Team Empowerment
    • NHS MedTech Business Case Formulation
  • Blog
  • Resources

Waiting List Rises Again

Related services

Let's talk

  • Richard Tuson
  • /
  • 12 Aug 2025

NHS waiting lists are still rising – reaching 7.37 million in June 2025, around 3 million higher than pre-COVID levels.

Despite 4.6 million extra elective appointments being delivered since July 2024, the list has only fallen by 253,000. The challenge is clear: capacity alone isn’t enough. To make a real impact, the NHS must focus on productivity – treating more patients in less time without compromising quality.

MedTech adoption is one of the few scalable solutions available. From reducing theatre time to enabling earlier discharge and supporting virtual care, the right technology can unlock measurable gains for patients and the system.

At Health Analytical Solutions Ltd, we bring over 20 years of experience in NHS coding, reimbursement, and policy change. We’ve worked with more than 150 technologies – including 30 with NICE approval – to help them navigate the complex route to adoption and secure reimbursement.

If you have a technology that can help the NHS deliver more, faster, and better, we can help you get it into use.

Our Latest Insights.

 
  • Richard Tuson

June 2025 NHS Diagnostic Waiting Lists

 
  • Richard Tuson

Community Diagnostic Centres: Extending Access and Reducing Delays

 
  • Richard Tuson

Where the Pressure Sits

 
  • Richard Tuson

Waiting List Rises Again

Health Analytical Solutions

  • About
  • Services
  • Blog
  • Resources
  • Contact Us

Services

  • Market Access Analytics and Insight
  • NICE HTA Strategy and Submission
  • Health Economics and Outcomes Research (HEOR)
  • Strategy Development
  • Reimbursement Strategy and Support
  • NHS Drug Tariff Submission Support
  • Private healthcare
  • Value Proposition Development for MedTech
  • Primary Care Market Insights
  • Stakeholder Engagement for Health Technologies
  • Sustainability and NET Zero for MedTech
  • Evidence Generation and Management
  • Dashboard Tools for Market Access
  • MedTech Sales Team Empowerment
  • NHS MedTech Business Case Formulation

Stay Up To Date

  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Contact Us

© Health Analytical Solutions 2025